Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes
Journal Title: Jornal de Pediatria - Year 2019, Vol 95, Issue 4
Abstract
Objective This large study with a long-term follow-up aimed to evaluate the clinical presentation, laboratory findings, histological profile, treatments, and outcomes of children and adolescents with autoimmune hepatitis. Methods The medical records of 828 children and adolescents with autoimmune hepatitis were reviewed. A questionnaire was used to collect anonymous data on clinical presentation, biochemical and histological findings, and treatments. Results Of all patients, 89.6% had autoimmune hepatitis-1 and 10.4% had autoimmune hepatitis-2. The female sex was predominant in both groups. The median age at symptom onset was 111.5 (6; 210) and 53.5 (8; 165) months in the patients with autoimmune hepatitis 1 and autoimmune hepatitis-2, respectively. Acute clinical onset was observed in 56.1% and 58.8% and insidious symptoms in 43.9% and 41.2% of the patients with autoimmune hepatitis-1 and autoimmune hepatitis-2, respectively. The risk of hepatic failure was 1.6-fold higher for autoimmune hepatitis-2. Fulminant hepatic failure occurred in 3.6% and 10.6% of the patients with autoimmune hepatitis-1 and autoimmune hepatitis-2, respectively; the risk was 3.1-fold higher for autoimmune hepatitis-2. The gamma globulin and immunoglobulin G levels were significantly higher in autoimmune hepatitis-1, while the immunoglobulin A and C3 levels were lower in autoimmune hepatitis-2. Cirrhosis was observed in 22.4% of the patients; biochemical remission was achieved in 76.2%. The actuarial survival rate was 93.0%. A total of 4.6% underwent liver transplantation, and 6.9% died (autoimmune hepatitis-1: 7.5%; autoimmune hepatitis-2: 2.4%). Conclusions In this large clinical series of Brazilian children and adolescents, autoimmune hepatitis-1 was more frequent, and patients with autoimmune hepatitis-2 exhibited higher disease remission rates with earlier response to treatment. Patients with autoimmune hepatitis-1 had a higher risk of death.
Authors and Affiliations
Gilda Porta
Keywords
Related Articles
- EP ID EP612706
- DOI 10.1016/j.jped.2018.04.007
- Views 77
- Downloads 0
The mediator role of psychological morbidity on sleep and health behaviors in adolescents
Objective This study examined the mediation role of psychological morbidity, defined in this study as depression/anxiety, in the relationship between excessive daytime sleepiness and sleep quality, and between sleep habi...
Predictive capacity of anthropometric indicators for dyslipidemia screening in children and adolescents
Objective To analyze the predictive capacity of anthropometric indicators and their cut-off values for dyslipidemia screening in children and adolescents. Methods This was a cross-sectional study involving 1139 children...
Tobacco smoke: it is time for pediatricians to feel directly concerned
It has been stated that the epidemic consequences of smoking-associated diseases rank among the greatest public health catastrophes in the past century.1 Many cancers as well as chronic diseases have tobacco as their spe...
Psychological preparation reduces preoperative anxiety in children. Randomized and double-blind trial
Objective To verify the effect of psychological preparation on the relief of preoperative anxiety in children and to correlate parents’ and children's levels of anxiety. Method After the approval of the institutional Re...
Prevalence and factors associated with smoking among adolescents
Objective Despite anti-smoking prevention programs, many adolescents start smoking at school age. The main objectives of this study were to determine the prevalence and risk factors associated with smoking in adolescents...